Scinai Strengthens I&I and CDMO Business via Recipharm Israel Deal
Scinai Immunotherapeutics Ltd., a biopharmaceutical company developing inflammation and immunology (I&I) therapeutics and operating a growing CDMO business, announced that it has acquired 100% of the shares of Recipharm Israel Ltd., which operates Recipharm's site in Yavne, Israel, and entered into a long-term str…
